Considering that cancer cells may activate alternative immune suppressive molecules to acquire the resistance to IFN induced by ICB treatment, we sought to search for the ICs most significantly associated with IFN signaling activation in GBM, which may provide new therapeutic target for this destructive tumor. Here, IFNA1 is linked to glioblastoma.